ClinicalTrials.Veeva

Menu

Comparison of D2 vs D3 Lymph Node Dissection for Right Colon Cancer (RICON)

G

G.V. Bondar Republican Cancer Center

Status

Active, not recruiting

Conditions

Colon Cancer

Treatments

Procedure: Right Hemicolectomy with D3 lymph node dissection
Procedure: Right Hemicolectomy with D2 lymph node dissection

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Comparing different method of surgical technique D2 lymph node dissection vs D3 for right colon cancer.

Enrollment

239 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Agreement of the patient to participate in trial
  2. Colon cancer (only adenocarcinoma )
  3. The tumor located between the cecum and the right 1/3 of transverse colon
  4. Tumors T3,Т4а,b N0-2 (II-III stages)
  5. Tolerance of chemotherapy
  6. ECOG 0-2

Exclusion criteria

  1. Patients with distant metastases
  2. Tumors T1-2 (I stage)
  3. Complications of tumor (perforation and full bowel obstruction)
  4. Previous radiotherapy or chemotherapy
  5. Synchronous or metachronous tumors
  6. Women during Pregnancy or breast feeding period

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

239 participants in 2 patient groups

D2 lymph node dissection for right colon cancer
Active Comparator group
Description:
Hemicolectomy for right colon cancer with D2 lymph node dissection
Treatment:
Procedure: Right Hemicolectomy with D2 lymph node dissection
D3 lymph node dissection for right colon cancer
Experimental group
Description:
Hemicolectomy for right colon cancer with D3 lymph node dissection
Treatment:
Procedure: Right Hemicolectomy with D3 lymph node dissection

Trial contacts and locations

1

Loading...

Central trial contact

Mihail Mutik, MD; Vladimir Balaban, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems